02 February 2024
14 November 2023
13 November 2023
26 October 2021
Jakarta, October 25th, 2021 – PT Soho Industri Pharmasi today handed over donation of 100,000 vials of Veklury® (remdesivir) from Gilead Sciences, Inc. to Ministry of Health (MoH) to support the ongoing COVID-19 pandemic in Indonesia.
“As cases of COVID-19 surge again around the world, and the pandemic continues to affect the lives of so many, we remain focused on ensuring that our medicines can reach patients that need them,” said Johanna Mercier, Chief Commercial Officer, Gilead Sciences. “These donations are the latest example of our ongoing commitment, and we will continue to work together with governments, health authorities and our voluntary licensing partners to ensure access to our medicines as quickly as possible.”
The Veklury donations will complement the supply of generic remdesivir provided through Gilead’s voluntary licensing program. Gilead is working closely with PT Soho Industri Pharmasi, a subsidiary of PT Soho Global Health, Tbk. (SOHO) and directly with the Governments of Indonesia to coordinate these donations. This donation handed over by Rogelio Paulino Jr. Castillo La O, President Director PT Soho Global Health, Tbk on behalf of Gilead to Drg. Arianti Anaya, MKM., Director General of Pharmaceuticals and Medical Devices, Ministry of Health of the Republic of Indonesia (MoH).
“We really appreciate PT Soho Industri Pharmasi for the efforts to facilitate Indonesian government through the Ministry of Health with Gilead Sciences, Inc in the donation of Veklury® (remdesivir) intended for the treatment of COVID-19 in Indonesia,” said Drg. Arianti Anaya, MKM., Director General of Pharmaceuticals and Medical Devices, MoH. Moreover, she said that the criteria determined for remdesivir recipients were the COVID-19 referral hospitals which have Isolation Room Facilities and Intensive Care Unit (ICU) considering that remdesivir is intended for COVID-19 patients with moderate to severe symptoms.
Meanwhile, said Catharina Siswanti Librawati, VP Alliance SOHO, SOHO's role as Gilead’s local distributor in Indonesia is to facilitate the Veklury® donation, given the fact that SOHO is Gilead's partner in selling and marketing of antivirus products in Indonesia."For this donation, SOHO fully supports Gilead’s initiative and facilitates each processes so that the implementation of Veklury® donation runs well and can support the treatment needs of COVID-19 patients in Indonesia," she said.
Gilead has previously donated at least 450,000 vials of Veklury to India, 10,000 vials of Veklury to Georgia and 3000 vials to Armenia. Veklury is approved or authorized for temporary use in approximately 50 countries worldwide. Gilead’s voluntary licensing program provides long-term licenses to nine manufacturers, to enable access to generic remdesivir in 127 countries, most of which are low- and low-middle income countries, including Indonesia. These licenses remain royalty-free, reflecting Gilead’s existing commitment to enabling broad patient access to remdesivir. Veklury and generic remdesivir have been made available to more than seven million patients around the world, including five million people in middle- and low-income countries through our voluntary licensing program.
list of media:
https://marketing.co.id/soho-donasikan-100-ribu-vial-veklury-dari-gilead-sciences/
https://akurat.co/terus-lawan-covid-19-kemenkes-dapat-100000-vial-remdesivir-dari-gilead-sciences
https://www.jawapos.com/nasional/25/10/2021/meski-kasus-turun-stok-obat-covid-19-tetap-dijamin-aman/
https://m.jpnn.com/news/pt-soho-industri-pharmasi-serahkan-100-ribu-vial-veklury-kepada-kemenkes
https://www.gatra.com/detail/news/526785?t=1
https://industri.kontan.co.id/news/gilead-sciences-serahkan-donasi-100000-vial-veklury-ke-indonesia
https://investor.id/lifestyle/268481/dukung-penanganan-pandemi-soho-donasi100-ribu-vial-veklury-nbsp
https://swa.co.id/covid19/soho-gilead-donasikan-100-ribu-vial-veklury
SOHO Global Health has consistently delivered sustainable, solid financial results despite the soft market condition. In a rapidly-changing environment, the key to our success has been our ability to balance continuity with change. It has required discipline and decisive actions to build sustainable value for the long term.
21 September 2020
12 September 09/12/19
15 August 08/15/18
16 July 07/16/18
16 July 07/16/18
16 July 07/16/18
Informasi pada website ini ditujukan untuk memberikan jawaban yang bersifat ilmiah, berdasarkan bukti ilmiah dan berimbang atas pertanyaan medis Anda.
Informasi ini tidak ditujukan sebagai saran medis. Perawatan pasien merupakan tanggung jawab praktisi kesehatan berdasarkan praktek perijinannya serta pengalaman dan informasi spesifik pasien.
